Short answer · Medically reviewed summary · Last updated: 2026-05-08
Palindromic Rheumatism is considered a rare condition, though precise global prevalence data remains elusive due to frequent underdiagnosis and misclassification. Estimates suggest an incidence of approximately 1 to 2 cases per 100,000 people annually, though these figures are limited by the episodic nature of the disease and its clinical overlap with other inflammatory conditions. Is Palindromic Rheumatism considered a rare disease? Yes, Palindromic Rheumatism is classified as a rare inflammatory disorder.
2 people with Palindromic Rheumatism have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Palindromic Rheumatism?
Prevalence of Palindromic Rheumatism: how many people are affected worldwide, differences by sex and region, with sources.
Palindromic Rheumatism is considered a rare condition, though precise global prevalence data remains elusive due to frequent underdiagnosis and misclassification. Estimates suggest an incidence of approximately 1 to 2 cases per 100,000 people annually, though these figures are limited by the episodic nature of the disease and its clinical overlap with other inflammatory conditions.
Is Palindromic Rheumatism considered a rare disease?
Yes, Palindromic Rheumatism is classified as a rare inflammatory disorder. Because symptoms of Palindromic Rheumatism are transient—often resolving completely between flares—many patients go undiagnosed or are misdiagnosed with other forms of inflammatory arthritis. Currently, 96 individuals living with Palindromic Rheumatism have joined the DiseaseMaps.org community, providing a vital real-world perspective on the diagnostic journey and the challenges of living with this elusive condition.
Who is most affected by Palindromic Rheumatism?
Research indicates that Palindromic Rheumatism affects males and females with roughly equal frequency, distinguishing it from many other autoimmune conditions that show a strong female bias. While Palindromic Rheumatism can occur at any age, the typical age of onset is between 20 and 50 years old. There is currently no definitive evidence suggesting significant geographic or ethnic variations in the prevalence of Palindromic Rheumatism, though further epidemiological study is required to confirm these findings.
What challenges exist in tracking Palindromic Rheumatism statistics?
Accurate tracking of Palindromic Rheumatism is hindered by several clinical factors:
- Episodic nature: Patients are often symptom-free during clinical evaluations, making objective assessment difficult.
- Diagnostic overlap: As 30-50% of patients with Palindromic Rheumatism eventually transition to Rheumatoid Arthritis, many cases are retrospectively reclassified.
- Lack of biomarkers: While rheumatoid factor can be present, its absence does not rule out the diagnosis, complicating population-wide screening efforts.
Next steps
- Consult with a board-certified rheumatologist to establish a long-term care plan.
- Track your flares and symptom duration to assist your physician in monitoring the progression of Palindromic Rheumatism.
- Join the DiseaseMaps.org community to connect with other patients and share experiences regarding treatment outcomes.
- Discuss preventative strategies with your specialist to mitigate the risk of developing secondary rheumatoid conditions.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Portal for rare diseases and orphan drugs
- PubMed: Clinical studies on the natural history of episodic inflammatory arthritis
- DiseaseMaps.org: Community-reported data and patient insights
https://www.hopkinsarthritis.org/physician-corner/rheumatology-rounds/round-1-palindromic-rheumatism
"depending which report you read, 1/8 to 1/20 that of rheumatoid arthritis"
Posted Oct 12, 2017 by Betty 200
According to the most recent studies, PR prevalence is somewhere between 1/20 or 1/8 of RA, which would put the number of those afflicted with PR in the USA between 65,000 and 162,000. There's also studies that suggest some people with RA start with PR and estimate that percentage around 10-15%, which would make the total afflicted in the USA around 195,000.
Due to misdiagnosis, under reporting, or simple lack of disease awareness, there are likely many more people afflicted around the world. But it's generally believed that PR is fairly rare, which is confirmed by the estimated number of .06% of the US population.
As for age and gender, it's known to affect men and women equally and is typically diagnosed between 20-50.
Posted Dec 1, 2019 by MaddOryxite 3570
